Search Page

1

Cite

Share

Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease.

Lukas J, Giese AK, Markoff A, Grittner U, Kolodny E, Mascher H, Lackner KJ, Meyer W, Wree P, Saviouk V, Rolfs A. Lukas J, et al. Among authors: meyer w. PLoS Genet. 2013;9(8):e1003632. doi: 10.1371/journal.pgen.1003632. Epub 2013 Aug 1. PLoS Genet. 2013. PMID: 23935525 Free PMC article.

Cite

Share

2

Cite

Share

[Antacids--an historical overview].

Meyer W. Meyer W. Pharm Unserer Zeit. 2007;36(1):10-20. doi: 10.1002/pauz.200600200. Pharm Unserer Zeit. 2007. PMID: 17283746 Review. German. No abstract available.

Cite

Share

3

Cite

Share

Autoantibodies in Myositis. How to Achieve a Comprehensive Strategy for Serological Testing.

Mende M, Borchardt-Lohölter V, Meyer W, Scheper T, Schlumberger W. Mende M, et al. Among authors: meyer w. Mediterr J Rheumatol. 2019 Sep 30;30(3):155-161. doi: 10.31138/mjr.30.3.155. eCollection 2019 Sep. Mediterr J Rheumatol. 2019. PMID: 32185358 Free PMC article. Review.

Cite

Share

4

Cite

Share

The effects of shift work on physical and mental health.

Vogel M, Braungardt T, Meyer W, Schneider W. Vogel M, et al. Among authors: meyer w. J Neural Transm (Vienna). 2012 Oct;119(10):1121-32. doi: 10.1007/s00702-012-0800-4. Epub 2012 Apr 10. J Neural Transm (Vienna). 2012. PMID: 22488445 Review.

Cite

Share

5

Cite

Share

Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.

Bogdanos DP, Gkoutzourelas A, Papadopoulos V, Liaskos C, Patrikiou E, Tsigalou C, Saratziotis A, Hajiioannou J, Scheper T, Meyer W, Sakkas LI, Papandreou C. Bogdanos DP, et al. Among authors: meyer w. Clin Chim Acta. 2021 Oct;521:199-205. doi: 10.1016/j.cca.2021.07.006. Epub 2021 Jul 8. Clin Chim Acta. 2021. PMID: 34245687

Cite

Share

6

Cite

Share

An update on behavioral treatments in migraine - current knowledge and future options.

Kropp P, Meyer B, Meyer W, Dresler T. Kropp P, et al. Among authors: meyer w. Expert Rev Neurother. 2017 Nov;17(11):1059-1068. doi: 10.1080/14737175.2017.1377611. Epub 2017 Sep 19. Expert Rev Neurother. 2017. PMID: 28877611 Review.

Cite

Share

7

Cite

Share

Antigen-specific humoral responses against Helicobacter pylori in patients with systemic sclerosis.

Efthymiou G, Liaskos C, Simopoulou T, Marou E, Patrikiou E, Scheper T, Meyer W, Daoussis D, Sakkas LI, Bogdanos DP. Efthymiou G, et al. Among authors: meyer w. Immunol Res. 2020 Feb;68(1):39-47. doi: 10.1007/s12026-020-09124-w. Immunol Res. 2020. PMID: 32253703

Cite

Share

8

Cite

Share

Disease-related autoantibody profile in patients with systemic sclerosis.

Liaskos C, Marou E, Simopoulou T, Barmakoudi M, Efthymiou G, Scheper T, Meyer W, Bogdanos DP, Sakkas LI. Liaskos C, et al. Among authors: meyer w. Autoimmunity. 2017 Nov;50(7):414-421. doi: 10.1080/08916934.2017.1357699. Epub 2017 Jul 27. Autoimmunity. 2017. PMID: 28749191

Cite

Share

9

Cite

Share

Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece.

Liaskos C, Marou E, Simopoulou T, Gkoutzourelas A, Barmakoudi M, Efthymiou G, Scheper T, Meyer W, Katsiari CG, Bogdanos DP, Sakkas LI. Liaskos C, et al. Among authors: meyer w. Mediterr J Rheumatol. 2018 Sep 27;29(3):120-126. doi: 10.31138/mjr.29.3.120. eCollection 2018 Sep. Mediterr J Rheumatol. 2018. PMID: 32185313 Free PMC article.

Cite

Share

10

Cite

Share

Autoantibodies against specific nuclear antigens are present in psoriatic disease and are diminished by secukinumab.

Patrikiou E, Liaskos C, Mavropoulos A, Ntavari N, Gkoutzourelas A, Simopoulou T, Fechner K, Scheper T, Meyer W, Katsiari CG, Roussaki-Schulze A, Zafiriou E, Sakkas LI, Bogdanos DP. Patrikiou E, et al. Among authors: meyer w. Clin Chim Acta. 2020 Nov;510:400-407. doi: 10.1016/j.cca.2020.07.037. Epub 2020 Jul 23. Clin Chim Acta. 2020. PMID: 32710943

Cite

Share